personnel as prescribed in clause 4(6) (7) (8) and (9) and harmonize with the elaborate commitment specified in its application unless where there is a difference in the details which does not cause such

personnel as prescribed in clause 4(6) (7) (8) and (9) and harmonize with the elaborate commitment specified in its application unless where there is a difference in the details which does not cause such

the paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that

paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that, prior

paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that, prior

this Notification shall lapse in the following cases: (1) expiration of the participation period of the regulatory sandbox under Clause 4(4) unless an approval is granted by the SEC Office to terminate

in the following cases: (1) expiration of the participation period of the regulatory sandbox under Clause 4(4) unless an approval is granted by the SEC Office to terminate the services prior to

in the following cases: (1) expiration of the participation period of the regulatory sandbox under Clause 4(4) unless an approval is granted by the SEC Office to terminate the services prior to

this Notification shall lapse in the following cases: (1) expiration of the participation period of the regulatory sandbox under Clause 3(4) unless an approval is granted by the SEC Office to terminate

under this Notification shall lapse in the following cases: (1) expiration of the participation period of the regulatory sandbox under Clause 3(4) unless an approval is granted by the SEC Office to